About Us
About Us
We Employ The Latest Research Techniques
Cellomatics Biosciences Ltd. is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology, Immuno-Oncology, Immunology, Inflammation and Respiratory therapeutic areas.
We provide bespoke pre-clinical/early discovery phase laboratory services to support Biotech, Pharmaceutical companies and Academic groups in their drug discovery projects. Our aim is to assist our clients in expediting their drug development programmes by providing high quality ethical services.
Cellomatics BioSciences is continually striving to offer added value to all our client discovery projects. We achieve this by constantly reviewing and evaluating new technologies that complement and augment our preclinical in vitro capabilities.
Key Facts
- Founded in 2015 and Privately owned
- Operating out of Biocity, Nottingham
- Experienced Management team with track record of delivering complex scientific projects
- Links with leading UK Universities
- Fully serviced laboratory with Specialised personnel
Our Services
Who can we support
Biotechnology Companies
Pharmaceutical Companies
Academic
Groups
Our Approach
0
Years in Operation
0
Projects completed
0
Clients worked with
How can we support you?
We offer a range of preclinical services:
TARGET VALIDATION We offer a range of strategies for modulating gene expression in vitro including the use of antibodies, negative dominant controls, antisense oligonucleotides,ribozymes and small-interfering RNAs.
IN VITRO CELL-BASED ASSAYS Cellomatics BioSciences also have expertise in designing, developing, performing and analysing functional cell-based assays using well-established cell lines and primary cells. We offer a comprehensive panel of cell-based functional assays using a vast selection of 2D and 3D cellular, co-culture models to determine the functional efficacy of your drug candidates.
BIOMARKER VALIDATION AND QUALIFICATION Molecular biomarkers are mainly used in early drug development, safety and proof of concept studies, as well as molecular profiling. Cellomatics BioSciences provides assay development and validation for prognostic/predictive clinical and pathway activation biomarkers:
- Multiplex Immunoassay
- Multiplex Nucleic Acid Testing
- Western Blot
- Clinical Chemistry Assays
- In-Cell ELISA
PREDICTIVE TOXICITY The main objective of pre-clinical testing is to determine the potential adverse effects, toxicity and drug/drug interactions before the drug is tested in either animal models or in a Phase 1 clinical trial. Hepato and renal in vitro toxicity tests are therefore vital for pre-screening drug compounds to reduce costs for in vivo testing and clinical trials. As the animal model might not mirror the human model completely, there is a powerful need to identify physiologically-relevant hepatic and kidney cellular models. Cellomatics BioSciences offers a vast selection of:
- 2D and 3D cellular models
- Biochemical
- Metabolic and genetic assays to detect drug toxicity, ADME, pharmacokinetic and toxicogenomics.
CONSULTANCY In consultation with you, we can design strategies for the identification and validation of targets and biomarkers to support your drug discovery programs. Our team of experienced scientists can provide consultancy to assist you in designing, developing, optimizing and validating your assays for your target and biomarker qualification work. We will provide regular electronic updates on the progress of your projects.
Request a Consultation with Cellomatics Biosciences Today
Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke
project plan with a professional, flexible service and a fast turnaround time.
project plan with a professional, flexible service and a fast turnaround time.
To request a consultation where we can discuss your exact requirements, please contact Cellomatics BioSciences on
Overview
Our Project Management
At Cellomatics BioSciences, we believe in efficient Project Management to ensure delivery of a high-quality work and complete client satisfaction.
Every project is assigned a Project Manager and a Project Director: a two-step Quality control approach. The Project Manager is the central contact point throughout the project life cycle with day to day operational responsibilities and management of the project team to produce high quality deliverables. The Project Director has an overall responsibility for the timely execution and delivery of the project within the agreed budget.
Key Stages of a Project Life Cycle
Project Initiation
Project Planning
Project Execution
Monitoring & Controlling
Project Closure
Project Feedback
Cellomatics Biosciences
Integrated Research Services
Our strengths lie in our team of staff scientists and consultants who are experts in bioassay development and validation. Our dynamic team of scientists have expertise in diverse technologies and therapeutic areas including Oncology, Immunology, Inflammation and Respiratory
With years of experience, they have the competencies to understand your requirements and deliver innovative and practical solutions. Our laboratory based in Biocity Nottingham is equipped with the state-of-the-art-technologies to provide validated and reproducible data to aid drug discovery for our partners.
Our Mission
Quality, Flexibility, Reliability and Customer Support
Our mission is to provide excellence in preclinical in vitro drug discovery to support our client’s quest for ethical, high quality cost-effective laboratory services. We accomplish this by adhering to our corporate core values including Integrity, Flexibility, Quality, Reliability and Accuracy.
Key Facts
- Founded in 2015 and Privately owned
- Located at Biocity Nottingham, UK
- Management team of highly skilled Scientists with track record of delivering complex scientific projects and peer reviewed international publications
- Fully serviced laboratory, working towards laboratory accreditation
- Strategic relationship with University of Leicester
- All Scientists are PhD qualified
Our Specialty
Why Choose Us
Therapeutic Area Expertise
We provide expertise in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory Therapeutic areas.
Value for money
We provide high quality services which are cost effective and meets our sponsor requirements.
Flexibility
We offer flexibility in our services to our sponsors so that they have the right science at the right time.
Customer Support
We provide regular updates on the projects progress.
Effective Time Management
Our objective is to work efficiently: from sample collection to project delivery.
Logistics Support
We work towards reducing your workload and stress.
Social Feed
Our expertise lies in developing customised solutions to support pre-clinical drug discovery programmes for our partners.
To discuss more about our CRO services,please contact us at info @cellomaticsbio.com
#cbioscien #preclinical #immunology #inflammation #oncology #respiratory https://t.co/3qohnjaL7k
Small packages of molecules known as exosomes have been found to cause the damage to lung tissue seen in COPD. Dislodging neutrophil elastase from exosomes, or inhibiting the enzyme or Mac-1, could be potential treatments.
contact:info @cellomaticsbio.com https://t.co/rwi4kpJR2U
Cellomatics #cbioscien have the complete capabilities to support your development of a potential vaccine for #COVIDー19, we are also well-positioned to assist our clients in the particular challenges of analytical method development and testing it on our invitro models. https://t.co/24pndvhVJB